GenAIz
Montreal company building purpose-built, deterministic AI tools for pharmaceutical and life-sciences R&D and compliance — literature review, conformity checks, regulatory filing and biomarker signature analysis — rather than general-purpose LLM assistants.
Canadian innovation builds a brighter tomorrow.
About
Company site: genaiz.comMontreal company building purpose-built, deterministic AI tools for pharmaceutical and life-sciences R&D and compliance — literature review, conformity checks, regulatory filing and biomarker signature analysis — rather than general-purpose LLM assistants.
States it 'favor[s] transparent, deterministic AI that you can trust, explain, and control', positioning its approach against off-the-shelf large language models. genaiz.com
Describes LitReview.AI as accelerating literature review with 'neural network matching tuned for biomedical purposes'. genaiz.com
States that CellCarta partnered with GenAIz to automate the T Cell Health Index, an analysis service assessing immune response in early-stage drug development. genaiz.com
Named in ALL IN's 2026 list of Canada's Top 100 AI startups. allinevent.ai
People
Sourced from the company's own pages or announcements.
Catherine Lunardi
Founder and CEO
Technology Focus
Company site: genaiz.comTerms the company uses about its own work.
Similar Companies
Other companies in AI.
